headquart san diego california
pure play diabet compani focus continu
reason report
price chang estim chang analysi
reiter o/v invest rate share
increas former price target per share
revenu growth clearli impress howev
opinion equal import mark improv
compani oper profil achiev profit
quarter also nine month date
oper period manufactur come on-lin partnership
walgreen nr enabl reduc cost burden
medicar patient manilla transit scale autom
invest leverag see clear line sight compani
long-term oper margin target opinion growth
margin expans acceler multipl re-rat higher
may still harbor competit concern view
oper progress undeni result reiter o/v
rate revis price target
increas price increas former
price target per share follow compani
price target assign revenu multipl
chang estim increas former
revenu estim fine-tun earn assumpt
specif increas former billion
revenu estim billion increas earn
estim per share respect likewis
increas former revenu estim billion
billion moder former earn estim
per share
annual revenu guidanc million million
revis rang million million pre-cal
consensu million addit compani lower gross
margin guidanc former rang
increas non-gaap oper margin guidanc
non-gaap ebitda margin guidanc
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
oper highlight oper period total revenu million pre-cal consensu
million increas specif domest sale increas year year million
intern sale growth increas year year million dxcm quarterli gross margin declin
year year pre-cal consensu compani report non-gaap oper margin
oper period versu oper period net incom million
per share includ million amort million busi transit relat cost
million non-cash interest expens adjust mention expens compani report non-gaap
earn per share pre-cal consensu per share oper period
pipelin track conjunct earn call compani reiter previous announc event
stand serv potenti posit catalyst enhanc growth margin profil long-term includ
full quarter compani new low cost transmitt associ reduct relat cog
versu exist transmitt doubl product capac estim late
earli launch compani much anticip next gener cgm platform
highlight report outstand quarter constant currenc revenu growth record
million absolut year-over-year dollar growth highest domest revenu growth sinc oper
period profit ytd launch canada furthermor septemb one compani
manufactur line went constrain capac said compani product mostli
advers impact begin oper period despit tempor manufactur issu
rais revenu guidanc impli annual sale growth versu prior guidanc
balanc sheet review exit oper period billion cash cash equival
billion debt net cash posit million equival net cash per share
dollar thousand except per share data
revenu
fiscal period
fiscal period
research develop
sell gener administr
research develop
sell gener administr
research develop
compani report stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
